Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Buy
71
ZBH Quote, Financials, Valuation and Earnings
Last price:
$107.32
Seasonality move
:
5.58%
Day range:
$106.27 - $107.44
52-week range:
$101.47 - $133.90
Dividend yield:
0.9%
P/E ratio:
20.40x
P/S ratio:
2.91x
P/B ratio:
1.73x
Volume:
457.8K
Avg. volume:
1.6M
1-year change:
-11%
Market cap:
$21.4B
Revenue:
$7.4B
EPS (TTM):
$5.26
Analysts' Opinion
-
Consensus RatingZimmer Biomet Holdings has received a consensus rating of Hold. The company's average rating is a Hold based on 6 Buy ratings, 17 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $124.27, Zimmer Biomet Holdings has an estimated upside of 15.81% from its current price of $107.30.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $107.00 representing 100% downside risk from its current price of $107.30.
Fair Value
-
According to the consensus of 24 analysts, Zimmer Biomet Holdings has 15.81% upside to fair value with a price target of $124.27 per share.
ZBH vs. S&P 500
-
Over the past 5 trading days, Zimmer Biomet Holdings has underperformed the S&P 500 by -3.55% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Zimmer Biomet Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Zimmer Biomet Holdings has grown year-over-year revenues for 8 quarters straight. In the most recent quarter Zimmer Biomet Holdings reported revenues of $1.8B.
Earnings Growth
-
Zimmer Biomet Holdings has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Zimmer Biomet Holdings reported earnings per share of $1.23.
Enterprise value:
27.4B
EV / Invested capital:
1.44x
Price / LTM sales:
2.91x
EV / EBIT:
22.10x
EV / Revenue:
3.60x
PEG ratio (5yr expected):
0.15x
EV / Free cash flow:
21.75x
Price / Operating cash flow:
17.56x
Enterprise value / EBITDA:
12.37x
Gross Profit (TTM):
$5.5B
Return On Assets:
5.04%
Net Income Margin (TTM):
14.27%
Return On Equity:
8.63%
Return On Invested Capital:
5.84%
Operating Margin:
17.33%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $6.9B | $7.3B | $7.6B | $1.8B | $1.8B | |
| Gross Profit | $4.9B | $5.2B | $5.5B | $1.2B | $1.3B | |
| Operating Income | $1.1B | $1.4B | $1.5B | $298.2M | $316.1M | |
| EBITDA | $1.5B | $1.8B | $2.2B | $511.5M | $535.5M | |
| Diluted EPS | $1.32 | $2.26 | $5.26 | $0.77 | $1.23 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5.2B | $5.3B | $4.5B | $4.4B | $4.9B | |
| Total Assets | $24B | $24B | $21.3B | $21.2B | $21.7B | |
| Current Liabilities | $2.3B | $2.9B | $2.3B | $2.1B | $3.6B | |
| Total Liabilities | $12.1B | $11.3B | $9.1B | $8.7B | $9.3B | |
| Total Equity | $11.9B | $12.7B | $12.3B | $12.5B | $12.4B | |
| Total Debt | $8.3B | $7.5B | $5.9B | $5.7B | $6.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.4B | $1.2B | $1.6B | $337.6M | $395.7M | |
| Cash From Investing | -$562.9M | -$670.6M | -$817.7M | -$165.6M | -$154.9M | |
| Cash From Financing | -$1.2B | -$825.5M | -$495.3M | -$196M | -$101.9M | |
| Free Cash Flow | $1.2B | $847.3M | $1.3B | $221.2M | $368.6M | |
ZBH
Sector
Market Cap
$21.4B
$46.1M
Price % of 52-Week High
80.13%
46.02%
Dividend Yield
0.9%
0%
Shareholder Yield
5.84%
-0.6%
1-Year Price Total Return
-11%
-30.52%
Beta (5-Year)
1.017
0.772
Dividend yield:
0.9%
Annualized payout:
$0.96
Payout ratio:
18.29%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$106.82
200-day SMA
Sell
Level
$112.68
Bollinger Bands (100)
Sell
Level
104.9 - 111.38
Chaikin Money Flow
Buy
Level
277M
20-day SMA
Sell
Level
$108.50
Relative Strength Index (RSI14)
Sell
Level
46.89
ADX Line
Buy
Level
7.98
Williams %R
Neutral
Level
-62.0643
50-day SMA
Sell
Level
$108.02
MACD (12, 26)
Sell
Level
-0.63
25-day Aroon Oscillator
Sell
Level
-84
On Balance Volume
Neutral
Level
1.5M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.9793)
Buy
CA Score
(Annual)
Level (0.2868)
Buy
Beneish M-Score
(Annual)
Level (-2.5642)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-2.0606)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Stock Forecast FAQ
In the current month, ZBH has received 6 Buy ratings 17 Hold ratings, and 1 Sell ratings. The ZBH average analyst price target in the past 3 months is $124.27.
-
Where Will Zimmer Biomet Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Zimmer Biomet Holdings share price will rise to $124.27 per share over the next 12 months.
-
What Do Analysts Say About Zimmer Biomet Holdings?
Analysts are divided on their view about Zimmer Biomet Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Zimmer Biomet Holdings is a Sell and believe this share price will drop from its current level to $107.00.
-
What Is Zimmer Biomet Holdings's Price Target?
The price target for Zimmer Biomet Holdings over the next 1-year time period is forecast to be $124.27 according to 24 Wall Street analysts, 6 of them rate the stock a Buy, 1 rates the stock a Sell, and 17 analysts rate the stock a Hold.
-
Is ZBH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Zimmer Biomet Holdings is a Hold. 17 of 24 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of ZBH?
You can purchase shares of Zimmer Biomet Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Zimmer Biomet Holdings shares.
-
What Is The Zimmer Biomet Holdings Share Price Today?
Zimmer Biomet Holdings was last trading at $107.32 per share. This represents the most recent stock quote for Zimmer Biomet Holdings. Yesterday, Zimmer Biomet Holdings closed at $107.30 per share.
-
How To Buy Zimmer Biomet Holdings Stock Online?
In order to purchase Zimmer Biomet Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
